Retour sur lavenir.net
   SYENSQO 66.500 € (+1,60 %)     AEDIFICA 71.550 € (+0,63 %)     AB INBEV 71.900 € (+0,67 %)     GIMV 49.500 € (+0,30 %)     ACKERMANS V.HAAREN 274.000 € (+0,51 %)     GBL 81.000 € (+1,12 %)     ARGENX SE 701.000 € (-0,74 %)     COLRUYT 33.460 € (+0,36 %)     MATERIALISE 5.100 € (+4,08 %)     COFINIMMO 84.050 € (+1,57 %)     WDP 22.020 € (-2,05 %)     AZELIS GROUP 10.310 € (-0,48 %)     VASTNED 29.500 € (0,00 %)     KBC 112.600 € (+2,04 %)     SOLVAY 26.000 € (+2,04 %)     LOTUS BAKERIES 10 840.000 € (-0,91 %)     KBC ANCORA 79.200 € (+1,93 %)     FAGRON 25.000 € (0,00 %)     ONTEX GROUP 2.660 € (-3,27 %)     TESSENDERLO 21.400 € (-0,23 %)     ECONOCOM GROUP 1.550 € (+3,33 %)     NYXOAH 2.450 € (+1,24 %)     IMMOBEL 21.800 € (0,00 %)     HOME INVEST BE. 18.940 € (-0,32 %)     DEME GROUP 187.000 € (-0,85 %)     TUBIZE-FIN 207.800 € (0,00 %)     XIOR 27.300 € (+1,30 %)     CARE PROPERTY INV. 13.180 € (-0,15 %)     CENERGY 24.020 € (+0,08 %)     BANQUP GROUP 2.450 € (+3,38 %)     BARCO 9.145 € (+1,55 %)     UMICORE 26.180 € (+5,74 %)     QRF 11.650 € (+2,19 %)     UCB 242.000 € (+0,46 %)     VAN DE VELDE 30.700 € (+0,66 %)     SOFINA 223.800 € (+0,54 %)     VIOHALCO 19.060 € (-2,16 %)     MELEXIS 81.450 € (+6,12 %)     WAREHOUSES ESTATES 40.000 € (-0,25 %)     TITAN S.A. 47.860 € (+1,27 %)     JENSEN-GROUP 76.400 € (-0,78 %)     CIE BOIS SAUVAGE 313.000 € (-1,26 %)     FLUXYS BELGIUM D 19.850 € (-1,73 %)     PROXIMUS 6.900 € (-0,29 %)     CMB.TECH 14.580 € (-3,19 %)     RECTICEL 10.720 € (+1,32 %)     BEKAERT 41.450 € (+2,47 %)     ASCENCIO 49.950 € (-1,09 %)     MONTEA 67.000 € (+0,60 %)     AGFA-GEVAERT 0.460 € (-0,43 %)     ELIA GROUP 137.600 € (-0,51 %)     BIOTALYS 2.880 € (-2,70 %)     D'IETEREN GROUP 167.500 € (+2,13 %)     SIPEF 95.200 € (+1,28 %)     IBA 15.380 € (-1,03 %)     NEXTENSA 46.000 € (+1,09 %)     RETAIL ESTATES 70.000 € (+1,30 %)     AGEAS 68.100 € (+0,52 %)     KINEPOLIS GROUP 29.300 € (-1,84 %)     EVS BROADC.EQUIPM. 31.150 € (-15,01 %)  
   RIBER 15.360 € (+16,54 %)     NN GROUP 75.840 € (+0,42 %)     VALLOUREC 24.040 € (-0,33 %)     RELX 28.380 € (-0,77 %)     DBV TECHNOLOGIES 3.182 € (-0,44 %)     SAINT GOBAIN 75.280 € (+1,67 %)     TIKEHAU CAPITAL 17.900 € (+2,52 %)     COFACE 16.440 € (+0,80 %)     UNIBAIL-RODAMCO-WE 97.600 € (-0,06 %)     WENDEL 88.900 € (+0,91 %)     LVMH 472.600 € (-0,20 %)     STMICROELECTRONICS 57.930 € (+5,17 %)     OPMOBILITY 15.300 € (+2,20 %)     GECINA 72.350 € (-0,48 %)     AIR FRANCE -KLM 10.255 € (+1,64 %)     ABN AMRO BANK N.V. 33.940 € (+1,65 %)     BASIC-FIT 29.900 € (-0,33 %)     DSM FIRMENICH AG 71.500 € (+0,25 %)     GTT 204.800 € (+0,59 %)     ADYEN 957.900 € (+1,58 %)     AMUNDI 85.700 € (-0,12 %)     METROPOLE TV 11.500 € (-0,17 %)     CARREFOUR 17.090 € (-1,07 %)     IPSEN 160.200 € (-0,25 %)     SODEXO 45.640 € (+0,13 %)     NOVACYT 0.580 € (+0,87 %)     ID LOGISTICS GROUP 362.500 € (-0,41 %)     ROCHE BOBOIS 25.600 € (-3,40 %)     ATOS 43.680 € (+7,22 %)     SES 8.950 € (+1,36 %)     2CRSI 46.700 € (+3,73 %)     NANOBIOTIX 36.460 € (+8,77 %)     FORVIA 10.375 € (+3,13 %)     AMG 38.640 € (+3,76 %)     SHELL PLC 37.110 € (-0,92 %)     AIRBUS 169.520 € (+2,15 %)     TRIGANO 153.600 € (-0,07 %)     BNP PARIBAS ACT.A 89.930 € (+0,86 %)     VIEL ET COMPAGNIE 18.900 € (+0,11 %)     ASR NEDERLAND 65.760 € (+1,20 %)     AALBERTS NV 38.760 € (+3,75 %)     REMY COINTREAU 40.600 € (-0,93 %)     VALEO 12.640 € (+2,39 %)     VICAT 61.800 € (+1,98 %)     ABIVAX 105.900 € (+0,76 %)     TOTALENERGIES 78.650 € (-2,01 %)     TELEPERFORMANCE 72.200 € (-1,45 %)     EKINOPS 3.100 € (+8,01 %)     ASML HOLDING 1 409.000 € (+4,74 %)     MERCIALYS 11.960 € (0,00 %)     QUADIENT 12.340 € (+3,01 %)     ALTEN 62.850 € (+1,05 %)     BILENDI 13.800 € (+0,29 %)     PHILIPS KON 23.370 € (+0,65 %)     CRCAM SUD R.A.CCI 245.500 € (+0,61 %)     AXA 40.120 € (+0,02 %)     KAUFMAN ET BROAD 25.050 € (+1,01 %)     WOLTERS KLUWER 62.500 € (-0,83 %)     L'OREAL 361.650 € (+0,61 %)     DANONE 61.860 € (-1,59 %)  
News Réglementées
30/04/2026 10:05

Demetra acquires Maxxspine Innovative GmbH, a company that has been a leader in advanced spinal solutions for over twenty years, further strengthening its position as a benchmark in spine surgery

EQS-News: Demetra Group / Key word(s): Mergers & Acquisitions
Demetra acquires Maxxspine Innovative GmbH, a company that has been a leader in advanced spinal solutions for over twenty years, further strengthening its position as a benchmark in spine surgery

30.04.2026 / 10:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


MILAN, April 30, 2026 /PRNewswire/ -- Demetra, an innovative and independent international medical company leader providing bone cements, spacers and biomaterials for orthopedic, spine and neuro applications and orthopedic infection control, announces the successful completion of the acquisition of Maxxspine Innovative GmbH, a German-based company specialized in advanced spinal surgery solutions. The transaction further strengthens Demetra's position as a benchmark international group in spine surgery.

Demetra Logo (PRNewsfoto/Demetra S.p.A.)

The acquisition has been completed by Osartis GmbH, a Demetra Group company, which has acquired 100% ownership and full control of Maxxspine Innovative GmbH, effective as of today.

Founded in Germany and established in 2010, Maxxspine is recognized for the development and distribution of cutting–edge medical devices for spinal surgery, with a strong presence in the German market and growing international footprint. Through this acquisition, Demetra significantly expands its spine portfolio and reinforces its proximity to surgeons and healthcare professionals in key European markets and beyond.

For over 40 years, Demetra has been a trusted partner to healthcare professionals worldwide, improving the lives of more than three million patients through advanced solutions in infection control, prosthesis fixation, orthobiologics and minimally invasive surgery. Operating through successfully established companies such as Tecres, Osartis and OsteoRemedies, Demetra continues to invest in innovation, people and long–term sustainable growth.

Following the completion of the transaction, Osartis will take global responsibility for Maxxspine's activities and will work closely with the existing management and teams over the coming months to ensure a smooth integration and continuity for customers and partners.

Volker Ludwig, CEO of Maxxspine Innovation, stated: "Becoming part of a strong and ambitious international group like Demetra provides the ideal platform to further develop what I have built over the years. This step makes me proud of our journey so far and confident in the results we can achieve together, with Maxxspine's values of trust and professionalism fully respected and carried forward".

After more than 20 years of delivering innovative, user-specific solutions in the spine business, we are now taking the next strategic step.

Through our integration into the Demetra Group, we significantly expand our capabilities, reach, and overall strength. This positions us to be recognized by both customers and suppliers as a reliable and forward-looking partner for the future. With Demetra at our side, we are unlocking new opportunities—particularly in the field of kyphoplasty. Together, we are well equipped to keep pace with global leaders and to further strengthen our position in this dynamic market.

Positioning for growth in the EU and beyond

"The acquisition of Maxxspine is fully aligned with Demetra's strategy to strengthen its presence in the key European spine surgery markets. By integrating highly specialised companies like Maxxspine, we further enhance our ability to stay close to surgeons and patients, delivering innovative solutions and reinforcing our role as a trusted international partner in spine care" commented Michele Perrino, CEO of Demetra.

About Demetra.

Demetra is an independent global healthcare group specialized in the development of PJI treatment solutions and minimally invasive surgical solutions. With a presence in over 100 countries and a growing portfolio of patented technologies, Demetra is committed to advancing patient care by investing in people, research, and sustainable innovation.

Logo - https://mma.prnewswire.com/media/2742564/5943698/Demetra_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/demetra-acquires-maxxspine-innovative-gmbh-a-company-that-has-been-a-leader-in-advanced-spinal-solutions-for-over-twenty-years-further-strengthening-its-position-as-a-benchmark-in-spine-surgery-302756391.html

rt.gif?NewsItemId=EN46278&Transmission_Id=202604300400PR_NEWS_EURO_ND__EN46278&DateId=20260430


30.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2319070  30.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière